GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Price-to-Tangible-Book

Ascendis Pharma AS (STU:A71) Price-to-Tangible-Book : (As of Jan. 18, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS Price-to-Tangible-Book?

As of today (2025-01-18), Ascendis Pharma AS's share price is €125.00. Ascendis Pharma AS's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was €-1.70. Hence, Ascendis Pharma AS's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Ascendis Pharma AS's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Ascendis Pharma AS's highest Price to Tangible Book Ratio was 76.87. The lowest was 2.62. And the median was 7.28.

STU:A71's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Ascendis Pharma AS's share price is €125.00. Ascendis Pharma AS's Book Value per Sharefor the quarter that ended in Sep. 2024 was €-1.63. Hence, Ascendis Pharma AS's P/B Ratio of today is .


Ascendis Pharma AS Price-to-Tangible-Book Historical Data

The historical data trend for Ascendis Pharma AS's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Price-to-Tangible-Book Chart

Ascendis Pharma AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.54 8.58 7.45 24.54 -

Ascendis Pharma AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ascendis Pharma AS's Price-to-Tangible-Book

For the Biotechnology subindustry, Ascendis Pharma AS's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma AS's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Price-to-Tangible-Book falls into.



Ascendis Pharma AS Price-to-Tangible-Book Calculation

Ascendis Pharma AS's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=125.00/-1.697
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Ascendis Pharma AS Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma AS Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines